• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Malignancy and immune disorders in patients with hereditary angioedema
CONCLUSIONS: Our case series identified multiple hereditary angioedema (HAE) patients with co-existing malignancy and immune disorders. Based on these findings, we would advocate that physicians managing HAE patients should maintain a high index of suspicion for these conditions and that in patients with angioedema, C1 inhibitor deficiency and malignancy, a diagnosis of HAE should still be considered in addition to acquired angioedema (AAE).PMID:34924008 | DOI:10.1186/s13223-021-00621-7
Source: Clinical Breast Cancer - December 20, 2021 Category: Cancer & Oncology Authors: Peter Stepaniuk Amin Kanani Source Type: research

Acute blue urticaria following subcutaneous injection of patent blue dye.
CONCLUSION: Blue acute urticaria is one of the clinical manifestations of immediate hypersensitivity reactions to patent blue dye. Skin tests must be performed 6 weeks after the reaction in order to confirm the diagnosis and formally contra-indicate this substance. PMID: 26372548 [PubMed - as supplied by publisher]
Source: Annales de Dermatologie et de Cenereologie - September 11, 2015 Category: Dermatology Authors: Hamelin A, Vial-Dupuy A, Lebrun-Vignes B, Francès C, Soria A, Barete S Tags: Ann Dermatol Venereol Source Type: research